News
GlobalData on MSN7h
Novartis’ ribociclib approved in Canada for early breast cancerHealth Canada has granted a notice of compliance for Novartis Canada’s Kisqali (ribociclib tablets) plus an aromatase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback